| Application no. and date | 14836725.3 (espacenet) (Federated) (European Patent Register), 20140807 | | Patent/reg. no. and date | DK/EP 3033104, 20190403 | | Publication date | 20160622 | | Priority no. and date | US 201361864948 P, 20130812 | | EP pub. no. and date |
EP 3033104 20160622 | | Effective date | | | Applicant/owner | AstraZeneca AB,
151 85 Södertälje, SE | | Applicant ref. no. | AST IL5R-604-EP-EPT | | Inventor | RAIBLE, Donald, 317 Lenape Drive
Berwyn, PA 19312, US,
WARD, Christine, c/o MedImmune, LLC
One MedImmune Way
Gaithersburg, MD 20878, US,
ROSKOS, Lorin, c/o MedImmune, LLC
One MedImmune Way
Gaithersburg, MD 20878, US,
WANG, Bing, c/o MedImmune, LLC
One MedImmune Way
Gaithersburg, MD 20878, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , G01N 33/48 (2006.01) | | Title | FREMGANGSMÅDER TIL FORØGELSE AF FORCERET EKSSPIRATORISK VOLUMEN HOS ASTMATIKERE VED ANVENDELSE AF BENRALIZUMAB | | Int. application no. | US2014050119 | | Int. publication no. | WO2015023507 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
